Generic immunosuppressants have reduced costs after organ transplantation

The introduction of generic versions of immunosuppressive drugs has resulted in substantial cost savings for transplant patients and Medicare, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

* This article was originally published here